BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 17290220)

  • 1. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2.
    Stevenson LF; Sparks A; Allende-Vega N; Xirodimas DP; Lane DP; Saville MK
    EMBO J; 2007 Feb; 26(4):976-86. PubMed ID: 17290220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MdmX is a substrate for the deubiquitinating enzyme USP2a.
    Allende-Vega N; Sparks A; Lane DP; Saville MK
    Oncogene; 2010 Jan; 29(3):432-41. PubMed ID: 19838211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2.
    Kim J; Keay SK; You S; Loda M; Freeman MR
    PLoS One; 2012; 7(12):e50392. PubMed ID: 23236372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.
    Meulmeester E; Pereg Y; Shiloh Y; Jochemsen AG
    Cell Cycle; 2005 Sep; 4(9):1166-70. PubMed ID: 16082221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulated oxidized USP2a can increase Mdm2-p60-p53 to promote cell apoptosis.
    Zhu H; Zhang H; Guo J; Zhang C; Zhang Q; Gao F
    Exp Cell Res; 2023 Jun; 427(1):113597. PubMed ID: 37044314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for Daxx in regulating Mdm2.
    Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X
    Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL; Gu W
    Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic role of HAUSP in the p53-Mdm2 pathway.
    Li M; Brooks CL; Kon N; Gu W
    Mol Cell; 2004 Mar; 13(6):879-86. PubMed ID: 15053880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53.
    Dayal S; Sparks A; Jacob J; Allende-Vega N; Lane DP; Saville MK
    J Biol Chem; 2009 Feb; 284(8):5030-41. PubMed ID: 19098288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.
    Ye M; Tang Y; Tang S; Liu J; Wu K; Yao S; Sun Y; Zhou L; Deng T; Chen Y; Huang C; Tan W
    Oncotarget; 2015 Oct; 6(33):34718-31. PubMed ID: 26460617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.
    Li M; Chen D; Shiloh A; Luo J; Nikolaev AY; Qin J; Gu W
    Nature; 2002 Apr; 416(6881):648-53. PubMed ID: 11923872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.
    Benassi B; Flavin R; Marchionni L; Zanata S; Pan Y; Chowdhury D; Marani M; Strano S; Muti P; Blandino G; Loda M
    Cancer Discov; 2012 Mar; 2(3):236-47. PubMed ID: 22585994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma.
    Wang CL; Wang JY; Liu ZY; Ma XM; Wang XW; Jin H; Zhang XP; Fu D; Hou LJ; Lu YC
    Carcinogenesis; 2014 Jul; 35(7):1500-9. PubMed ID: 24445145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the p53/MDM2 interplay by HAUSP inhibitors.
    Tavana O; Gu W
    J Mol Cell Biol; 2017 Feb; 9(1):45-52. PubMed ID: 27927749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
    Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
    PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction.
    Shiheido H; Takashima H; Doi N; Yanagawa H
    PLoS One; 2011 Mar; 6(3):e17898. PubMed ID: 21423613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
    Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
    Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.